Statistics for KNIGHT THERAPEUTICS INC (id:13521 GUD)

Valuation metrics

Market cap

534.26M

Enterprise value

411.08M

Trailing P/E (ttm)

-33.13

Forward P/E

58.89

PEG ratio

58.89

Price/Sales (ttm)

1.53

Price/Book (mrq)

0.69

Enterprise Value/Revenue

1.18

Enterprise Value/EBITDA

7.17

Overview

Shares outstanding

100.80M

Float

86.03M

Shares short

2.94M

% Held by insiders

0.46%

% Held by institutions

0.12%

Average volume (10 days)

142.25K

Average volume (90 days)

Price summary

52-Week low

5.07

52-Week high

6.23

52-Week change

-0.76%

Beta

0.52

50-Day moving average

5.69

200-Day moving average

5.66

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

-8.81%

Operating margin

3.47%

Operational effectiveness

Return on assets

0.65%

Return on equity

-3.87%

Income statement

Revenue (ttm)

3.42

Revenue per share (ttm)

3.42

Quarterly revenue growth (yoy)

-0.99

Gross profit (ttm)

152.65M

EBITDA

73.49M

Net income to common (ttm)

-30,729,000.00

Diluted EPS (ttm)

-0.29

Quarterly earnings growth (yoy)

-99.10%

Balance sheet

Total cash (mrq)

172.32M

Total cash per share (mrq)

1.71

Total debt (mrq)

58.22M

Total Debt/Equity (mrq)

7.52

Current ratio (mrq)

336.50%

Book value per share (mrq)

7.66

Cash flow

Cash flow statement

52.75M

Levered free cash flow (LFCF)

45.96M